Fibrates in the treatment of dyslipidemias--time for a reassessment

N Engl J Med. 2011 Aug 11;365(6):481-4. doi: 10.1056/NEJMp1106688.

Authors

Allison B Goldfine¹, Sanjay Kaul, William R Hiatt

Affiliation

¹ Joslin Diabetes Center and Harvard Medical School, Boston, USA.

PMID: 21830963
DOI: 10.1056/NEJMp1106688

No abstract available

MeSH terms

Advisory Committees
Cardiovascular Diseases / prevention & control
Diabetes Mellitus, Type 2 / drug therapy
Drug Therapy, Combination
Dyslipidemias / drug therapy*
Fenofibrate / therapeutic use*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
United States
United States Food and Drug Administration

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Fenofibrate